Immunology

Cutting-edge research pt.1

The IBMS has awarded five research grants this year. Here, the first two successful candidates outline the work they are undertaking.

British Journal of Biomedical Science Issue 4 2018: a synopsis

The hard copy of the autumn issue of our journal is complete. Editor Andrew Blann outlines the content of the latest issue, which includes six papers that use techniques in molecular genetics.

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

Vaccine to treat lung cancer

A first-of-its-kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung cancer.

July: Journal-based learning

Each article’s contents should be read, researched and understood, and you should then come to a decision on each question. The pass mark is 17 out of 20 questions answered correctly. JBL exercises may be completed at any time until the published deadline date. Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Antibiotic resistance and microwaves

Lecturer in Molecular Microbiology Tina Joshi looks at the detection of antimicrobial-resistant bacteria in the timeframe of a doctor’s appointment.

New delivery method for immunotherapy combination

Using nanoparticles to bind molecules that can unleash and stimulate immune cells, US researchers found they could more effectively trigger the body’s defence systems against cancer in laboratory studies.

"One-stop shop to speed up cancer diagnosis"

Special centres that are aimed at speeding up cancer diagnosis are being introduced across Englan

How did gonorrhoea become drug resistant?

Mutations to the bacterium Neisseria gonorrhoea have been identified, that enable resistance to ceftriaxone, which could lead to the global spread of ceftriaxone-resistant “superbug” strains.

Top